EDGAR Filing Documents for 0001654954-18-005724

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-18-005724

Filing Date

2018-05-22

Accepted

2018-05-21 17:56:13

Documents

Period of Report

2018-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	sbfm_10q.htm	10-Q	440965
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex311.htm	EX-31.1	12302
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex312.htm	EX-31.2	11960
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32	7026
5	IMAGE	sbfm_10q000.jpg	GRAPHIC	8643
6	IMAGE	sbfm_10q001.jpg	GRAPHIC	21693
7	IMAGE	sbfm_10q002.jpg	GRAPHIC	20336
8	IMAGE	sbfm_10q003.jpg	GRAPHIC	11277
	Complete submission text file	0001654954-18-005724.txt		1348247

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	sbfm-20180331.xml	EX-101.INS	69214
10	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20180331.xsd	EX-101.SCH	15593
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20180331_cal.xml	EX-101.CAL	39575
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20180331_def.xml	EX-101.DEF	16719
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20180331_lab.xml	EX-101.LAB	112656
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20180331_pre.xml	EX-101.PRE	80570

Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4

Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)